Archives

by in
Entry Author Date Location
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up 05/09/13 Texas
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
The Fiscal Cliff Is Forcing a Biomedical Day of Reckoning 12/31/12 National
Isis Pharmaceuticals Adds More Deals to Partnership Portfolio 12/12/12 San Diego
Alnylam, Tekmira Look Ahead After RNAi Divorce 11/14/12 Boston
Alnylam to Pay Tekmira $65M to Settle RNAi Delivery Dispute 11/12/12 Boston
Sarepta Drug Helps Boys With Duchenne to Walk; Shares Boom 10/03/12 Boston
Alnylam Inks $29M Deal With Monsanto for New Bio Tools for Farmers 08/28/12 Boston
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
Alnylam Stock Climbs on Positive Early Trial for Amyloidosis 07/16/12 Boston
Marina Biotech Runs Out of Cash, Axes 90% of Staff 06/01/12 Seattle
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans 01/19/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of 12/13/11 Boston
Marina Biotech Finds $15M From Investor to Keep Pursuing RNAi Drugs 10/17/11 Seattle
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
Marina Biotech Ends Bothell Lease on Nasal Spray Building, Coughs up Shares to Landlord 10/04/11 Seattle
Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore 10/04/11 National
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam 09/28/11 National
Page 1 of 6 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.